Is Verastem, Inc. (VSTM) a Buy, Sell, or Hold?
NASDAQ : VSTM
Verastem, Inc. — Institutional Ownership
$6.79 USD
$0.05 (0.74%)
- Volume
- 2.29M
- Average Volume
- 2.47M
- Market Capitalization
- $596.66M
- P/E Ratio
- -2.76
- Dividend Yield
- 0.00%
- Price Target
- $13.50
- Year High
- $11.25
- Year Low
- $3.43
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.25
Institutional Ownership Summary
Institutional Ownership %
19.39%
Investors Holding
49
change: -113.0 | last: 162
Increased Positions
36
change: -77.0 | last: 113
Reduced Positions
6
change: -20.0 | last: 26
New Positions
17
change: -23.0 | last: 40
Sold Positions
125
change: 98.0 | last: 27
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -4.5339 | last: 0.0453
Total Invested
72.89M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-08-07 | STATE STREET CORPORATION | 5.13M | 5.80% |
| 2026-07-31 | Vanguard Capital Management | 4.42M | 5.03% |
| 2026-05-15 | Foresite Capital Fund VI LP | 3.15M | 3.60% |
| 2026-05-15 | RTW Investments, LP | 9.02M | 9.90% |
| 2026-05-15 | Armistice Capital, LLC | 4.59M | 5.23% |
| 2026-05-15 | Balyasny Asset Management L.P. | 1.36M | 1.55% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Armistice Capital, LLC | 3.54M | 5.30% |
| 2026-02-17 | Point72 Asset Management, L.P. | 995.03K | 1.30% |
| 2026-02-17 | RTW Investments, LP | 7.84M | 9.90% |
| 2026-02-17 | Balyasny Asset Management L.P. | 4.77M | 6.18% |
| 2026-02-13 | Nantahala Capital Management, LLC | 3.8M | 4.72% |
| 2026-01-05 | Polar Capital Holdings Plc | 3.4M | 5.09% |
| 2025-11-21 | Deep Track Capital, LP | 7.72M | 9.99% |
| 2025-11-14 | Nantahala Capital Management, LLC | 4.63M | 7.13% |
| 2025-11-14 | Balyasny Asset Management L.P. | 5.72M | 9.29% |
| 2025-11-14 | Logos Global Management LP | 3.18M | 4.80% |
| 2025-11-13 | Stonepine Capital Management, LLC | 2.67M | 4.30% |
| 2025-10-23 | Foresite Capital Fund VI LP | 3.14M | 5.10% |
| 2025-10-17 | BlackRock, Inc. | 3.68M | 6.00% |
| 2025-08-14 | RTW Investments, LP | 5.63M | 9.90% |
| 2025-08-14 | Balyasny Asset Management L.P. | 5.78M | 9.99% |
| 2025-08-14 | ORBIMED ADVISORS LLC | 1.33M | 2.40% |
| 2025-08-13 | BIOTECHNOLOGY VALUE FUND L P | 1.4M | 2.20% |
| 2025-08-13 | BIOTECHNOLOGY VALUE FUND L P | 3.24M | 5.80% |
| 2025-08-06 | Stonepine Capital Management, LLC | 2.83M | 5.00% |
| 2025-07-29 | Orin Hirschman | 2M | 3.60% |
| 2025-07-29 | The Vanguard Group | 3.42M | 6.23% |
| 2025-07-28 | Logos Global Management LP | 3.42M | 6.20% |
| 2025-07-28 | Point72 Asset Management, L.P. | 3.34M | 6.10% |
| 2025-05-15 | Nantahala Capital Management, LLC | 5.46M | 9.99% |
| 2025-05-15 | Balyasny Asset Management L.P. | 4.79M | 9.30% |
| 2025-05-15 | RTW Investments, LP | 4.25M | 8.30% |
| 2025-05-15 | OrbiMed Advisors LLC | 2.86M | 5.60% |
| 2025-05-02 | Soleus Private Equity Fund III, L.P. | 343.52K | 0.70% |
| 2025-04-30 | The Vanguard Group | 2.43M | 4.71% |
| 2025-04-24 | BlackRock, Inc. | 2.52M | 4.90% |
| 2025-03-21 | Barclays PLC | 3.95M | 8.87% |
| 2025-02-14 | Alyeska Investment Group, L.P. | 1M | 2.10% |
| 2025-02-14 | BIOTECHNOLOGY VALUE FUND L P | 2.79M | 6.00% |
| 2025-02-14 | Balyasny Asset Management L.P. | 3.95M | 8.87% |
| 2025-02-14 | Ramya Rao | 3.95M | 8.87% |
| 2025-02-14 | Nantahala Capital Management, LLC | 4.52M | 9.99% |
| 2025-02-13 | Stonepine Capital Management, LLC | 2.2M | 4.80% |
| 2025-02-11 | Soleus Private Equity Fund III, L.P. | 1.79M | 3.90% |
| 2025-01-31 | The Vanguard Group | 2.31M | 5.19% |
| 2025-01-21 | Orin Hirschman | 2.72M | 6.10% |
| 2024-11-14 | Alyeska Fund GP, LLC | 2.86M | 7.11% |
| 2024-11-14 | Alyeska Investment Group, L.P. | 2.86M | 7.11% |
| 2024-11-14 | Anand Parekh | 2.86M | 7.11% |
| 2024-11-14 | Alyeska Fund GP, LLC | 2.86M | 7.11% |
| 2024-11-14 | Alyeska Investment Group, L.P. | 2.86M | 7.11% |
| 2024-11-14 | Anand Parekh | 2.86M | 7.11% |
| 2024-11-08 | (1) BlackRock, Inc. | 2.23M | 5.60% |
| 2024-10-24 | (1) BlackRock, Inc. | 2.23M | 5.60% |
| 2024-07-29 | Stonepine Capital, L.P. | 2.67M | 11.00% |
| 2024-07-29 | Timothy P. Lynch | 2.67M | 11.00% |
| 2024-07-29 | Stonepine Capital Management, LLC | 2.67M | 11.00% |
| 2024-07-29 | Stonepine GP, LLC | 2.67M | 11.00% |
| 2024-07-29 | Jon M. Plexico | 2.67M | 11.00% |
| 2024-07-29 | Stonepine GP, LLC | 2.67M | 11.00% |
| 2024-07-29 | Jon M. Plexico | 2.67M | 11.00% |
| 2024-07-29 | Stonepine Capital, L.P. | 2.67M | 11.00% |
| 2024-07-29 | Stonepine Capital Management, LLC | 2.67M | 11.00% |
| 2024-07-29 | Timothy P. Lynch | 2.67M | 11.00% |
| 2023-08-31 | Adage Capital Partners, L.P. | 1.3M | 5.15% |
| 2023-08-31 | Adage Capital Partners, L.P. | 1.3M | 5.15% |
| 2023-08-31 | Adage Capital Management, L.P. | 1.3M | 5.15% |
| 2023-08-31 | Adage Capital Partners GP, L.L.C. | 1.3M | 5.15% |
| 2023-08-31 | Phillip Gross | 1.3M | 5.15% |
| 2023-08-31 | Robert Atchinson | 1.3M | 5.15% |
| 2023-08-31 | Robert Atchinson | 1.3M | 5.15% |
| 2023-08-31 | Adage Capital Partners GP, L.L.C. | 1.3M | 5.15% |
| 2023-08-31 | Adage Capital Management, L.P. | 1.3M | 5.15% |
| 2023-08-31 | Phillip Gross | 1.3M | 5.15% |
| 2023-07-27 | Master Fund, L.P. | 1.3M | 5.10% |
| 2023-07-27 | LLC | 1.3M | 5.10% |
| 2023-07-27 | Group, LLC | 1.3M | 5.10% |
| 2023-07-27 | Levy | 1.3M | 5.10% |
| 2023-07-27 | Master Fund, L.P. | 1.3M | 5.10% |
| 2023-07-27 | LLC | 1.3M | 5.10% |
| 2023-07-27 | Group, LLC | 1.3M | 5.10% |
| 2023-07-27 | Levy | 1.3M | 5.10% |
| 2023-06-23 | Deerfield Mgmt, L.P. | 1.54M | 6.10% |
| 2023-06-23 | James E. Flynn | 1.54M | 6.10% |
| 2023-06-23 | James E. Flynn | 1.54M | 6.10% |
| 2023-06-23 | Deerfield Partners, L.P. | 1.54M | 6.10% |
| 2023-06-23 | Company, L.P. | 1.54M | 6.10% |
| 2023-06-23 | Deerfield Mgmt, L.P. | 1.54M | 6.10% |
| 2023-06-23 | Company, L.P. | 1.54M | 6.10% |
| 2023-06-23 | Deerfield Partners, L.P. | 1.54M | 6.10% |
| 2023-06-05 | Viking Global Investors LP | 1.32M | 7.90% |
| 2023-06-05 | Viking Global Investors LP | 1.32M | 7.90% |
| 2023-02-14 | OrbiMed Capital GP IX LLC | 12.35M | 5.90% |
| 2023-02-14 | OrbiMed Advisors LLC | 16.5M | 7.90% |
| 2023-02-14 | OrbiMed Capital GP IX LLC | 12.35M | 5.90% |
| 2023-02-14 | OrbiMed Advisors LLC | 16.5M | 7.90% |
| 2022-07-08 | (1) BlackRock, Inc. | 4.34M | 2.30% |
| 2022-02-14 | Felix J. Baker | 21.49M | 11.80% |
| 2022-02-14 | Julian C. Baker | 21.49M | 11.80% |
| 2022-02-14 | Baker Bros. Advisors (GP) LLC | 21.49M | 11.80% |
| 2022-02-14 | Baker Bros. Advisors LP | 21.49M | 11.80% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 8.85M | 4.86% |
| 2022-02-03 | (1) BlackRock, Inc. | 12.33M | 6.80% |
| 2022-01-10 | Biotechnology Value Fund, L.P. | 8.82M | 4.80% |
| 2022-01-10 | Biotechnology Value Fund, L.P. | 9.58M | 5.30% |
| 2021-05-10 | Felix J. Baker | 18.69M | 10.90% |
| 2021-05-10 | Felix J. Baker | 18.69M | 10.90% |
| 2021-05-10 | Baker Bros. Advisors (GP) LLC | 18.69M | 10.90% |
| 2021-05-10 | Baker Bros. Advisors LP | 18.69M | 10.90% |
| 2021-05-10 | Baker Bros. Advisors (GP) LLC | 18.69M | 10.90% |
| 2021-05-10 | Baker Bros. Advisors LP | 18.69M | 10.90% |
| 2021-05-10 | Julian C. Baker | 18.69M | 10.90% |
| 2021-05-10 | Julian C. Baker | 18.69M | 10.90% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | Julian C. Baker | 10.14M | 6.00% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | Point72 Hong Kong Limited | 27.0 | 4.00% |
| 2021-02-16 | Baker Bros. Advisors LP | 10.14M | 6.00% |
| 2021-02-16 | Steven A. Cohen | 6604.0 | 4.00% |
| 2021-02-16 | Kenneth Griffin | 10.0 | 0.20% |
| 2021-02-16 | Citadel GP LLC | 10.0 | 0.10% |
| 2021-02-16 | Kenneth Griffin | 10.0 | 0.20% |
| 2021-02-16 | Baker Bros. Advisors (GP) LLC | 10.14M | 6.00% |
| 2021-02-16 | Rajeev Shah | - | 0.00% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | Cubist Systematic Strategies, LLC | 6577.0 | 4.00% |
| 2021-02-16 | Peter Kolchinsky | - | 0.00% |
| 2021-02-16 | Julian C. Baker | 10.14M | 6.00% |
| 2021-02-16 | Felix J. Baker | 10.14M | 6.00% |
| 2021-02-16 | Peter Kolchinsky | - | 0.00% |
| 2021-02-16 | RA Capital Management, L.P. | - | 0.00% |
| 2021-02-16 | Ridgeback Capital Management LLC 42-1684320 | - | 0.00% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | 72-1614961 | - | 0.00% |
| 2021-02-16 | L.P. 66-0677421 | - | 0.00% |
| 2021-02-16 | Felix J. Baker | 10.14M | 6.00% |
| 2021-02-16 | L.P. 66-0677421 | - | 0.00% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | Citadel GP LLC | 10.0 | 0.10% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | Point72 Capital Advisors, Inc. | - | 4.00% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | Baker Bros. Advisors LP | 10.14M | 6.00% |
| 2021-02-16 | Point72 Asset Management, L.P. | - | 4.00% |
| 2021-02-16 | Baker Bros. Advisors (GP) LLC | 10.14M | 6.00% |
| 2021-02-16 | RA Capital Management, L.P. | - | 0.00% |
| 2021-02-16 | 2. | 10.0 | 0.10% |
| 2021-02-16 | Rajeev Shah | - | 0.00% |
| 2021-02-12 | Ikarian Healthcare Fund GP, L.P. | 1.76M | 1.00% |
| 2021-02-12 | Neil Shahrestani | 2.25M | 1.30% |
| 2021-02-12 | Neil Shahrestani | 2.25M | 1.30% |
| 2021-02-12 | Ikarian Healthcare Fund GP, L.P. | 1.76M | 1.00% |
| 2021-02-12 | Chart Westcott | 2.25M | 1.30% |
| 2021-02-12 | Ikarian Healthcare Master Fund, L.P. | 1.76M | 1.00% |
| 2021-02-12 | Vivo Capital IX, LLC | - | 0.00% |
| 2021-02-12 | Ikarian Healthcare Master Fund, L.P. | 1.76M | 1.00% |
| 2021-02-12 | Ikarian Capital, LLC | 2.25M | 1.30% |
| 2021-02-12 | Vivo Opportunity, LLC | - | 0.00% |
| 2021-02-12 | Ikarian Capital, LLC | 2.25M | 1.30% |
| 2021-02-12 | Chart Westcott | 2.25M | 1.30% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 9.01M | 5.31% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 9.01M | 5.31% |
| 2021-02-05 | Highbridge Tactical Credit Master Fund, L.P. | 8.62M | 4.83% |
| 2021-02-05 | Highbridge Tactical Credit Master Fund, L.P. | 8.62M | 4.83% |
| 2021-02-05 | Highbridge Capital Management, LLC | 8.62M | 4.83% |
| 2021-02-05 | Highbridge Capital Management, LLC | 8.62M | 4.83% |
| 2021-02-02 | (1) BlackRock, Inc. | 13.49M | 7.90% |
| 2020-03-11 | Vivo Capital IX, LLC | 1.48M | 1.10% |
| 2020-03-11 | Vivo Capital IX, LLC | 1.48M | 1.10% |
| 2020-03-11 | Vivo Opportunity, LLC | 6.65M | 4.80% |
| 2020-03-11 | Vivo Opportunity, LLC | 6.65M | 4.80% |
| 2020-03-09 | Ikarian Capital, LLC | 5.05M | 6.80% |
| 2020-03-09 | Ikarian Capital, LLC | 5.05M | 6.80% |
| 2020-03-09 | Ikarian Healthcare Master Fund, L.P. | 3.88M | 5.20% |
| 2020-03-09 | Neil Shahrestani | 5.05M | 6.80% |
| 2020-03-09 | Ikarian Healthcare Fund GP, L.P. | 3.88M | 5.20% |
| 2020-03-09 | Chart Westcott | 5.05M | 6.80% |
| 2020-03-09 | Neil Shahrestani | 5.05M | 6.80% |
| 2020-03-09 | Chart Westcott | 5.05M | 6.80% |
| 2020-03-09 | Ikarian Healthcare Master Fund, L.P. | 3.88M | 5.20% |
| 2020-03-09 | Ikarian Healthcare Fund GP, L.P. | 3.88M | 5.20% |
| 2020-03-06 | Ridgeback Capital Investments L.P. 00-0000000 | 10.07M | 8.30% |
| 2020-03-05 | RA Capital Management, L.P. | 18.6M | 13.50% |
| 2020-03-05 | RA Capital Management, L.P. | 18.6M | 13.50% |
| 2020-02-14 | BVF GP HOLDING LLC | 5.66M | 7.60% |
| 2020-02-14 | BVF I GP LLC | 3.13M | 4.20% |
| 2020-02-14 | 2. | 10.0 | 0.30% |
| 2020-02-14 | 2. | 10.0 | 0.30% |
| 2020-02-14 | 2. | 10.0 | 8.00% |
| 2020-02-14 | BVF Partners OS Ltd. | 450.5K | 1.00% |
| 2020-02-14 | BVF II GP LLC | 2.53M | 3.40% |
| 2020-02-14 | BVF Partners L.P. | 6.33M | 8.50% |
| 2020-02-14 | Biotechnology Value Fund, L.P. | 3.13M | 4.20% |
| 2020-02-14 | Mark N. Lampert | 6.33M | 8.50% |
| 2020-02-14 | 2. | 10.0 | 7.70% |
| 2020-02-14 | 2. | 10.0 | 7.70% |
| 2020-02-14 | 2. | 10.0 | 7.70% |
| 2020-02-14 | Biotechnology Value Trading Fund OS LP | 450.5K | 1.00% |
| 2020-02-14 | BVF Inc. | 6.33M | 8.50% |
| 2020-02-14 | 2. | 10.0 | 0.30% |
| 2020-02-14 | Biotechnology Value Fund II, L.P. | 2.53M | 3.40% |
| 2020-02-13 | Highbridge Capital Management, LLC | 10.22M | 9.99% |
| 2020-02-13 | as 1992 Tactical Credit Master Fund, L.P.) | 10.22M | 9.99% |
| 2020-02-13 | Highbridge Capital Management, LLC | 10.22M | 9.99% |
| 2020-02-13 | as 1992 Tactical Credit Master Fund, L.P.) | 10.22M | 9.99% |
| 2020-02-03 | Steven A. Cohen | 5.51M | 4.00% |
| 2020-02-03 | Point72 Asset Management, L.P. | 5.5M | 4.00% |
| 2020-02-03 | Point72 Capital Advisors, Inc. | 5.5M | 4.00% |
| 2020-02-03 | Cubist Systematic Strategies, LLC | 13953.0 | 4.00% |
| 2020-01-21 | 2. | 10.07M | 12.60% |
| 2020-01-21 | 2. | 10.07M | 12.60% |
| 2020-01-21 | 2. | 10.07M | 12.60% |
| 2020-01-21 | 2. | 10.07M | 12.60% |
| 2020-01-21 | 2. | 10.07M | 12.60% |
| 2020-01-21 | 2. | 10.07M | 12.60% |
| 2019-12-03 | 2. | 10.0 | 8.80% |
| 2019-12-03 | 2. | 10.0 | 8.80% |
| 2019-12-03 | 2. | 10.0 | 0.30% |
| 2019-12-03 | 2. | 10.0 | 8.80% |
| 2019-12-03 | 2. | 10.0 | 9.10% |
| 2019-12-03 | 2. | 10.0 | 0.30% |
| 2019-12-03 | 2. | 10.0 | 0.30% |
| 2019-11-04 | Highbridge Capital Management, LLC | 4.07M | 5.18% |
| 2019-11-04 | 1992 Tactical Credit Master Fund, L.P. | 4.07M | 5.18% |
| 2019-11-04 | Highbridge Capital Management, LLC | 4.07M | 5.18% |
| 2019-11-04 | 1992 Tactical Credit Master Fund, L.P. | 4.07M | 5.18% |
| 2019-05-20 | Mark N. Lampert | 5.51M | 7.50% |
| 2019-05-20 | Biotechnology Value Fund, L.P. | 2.71M | 3.70% |
| 2019-05-20 | Biotechnology Value Trading Fund OS LP | 390.15K | 1.00% |
| 2019-05-20 | BVF Partners OS Ltd. | 390.15K | 1.00% |
| 2019-05-20 | BVF Partners L.P. | 5.51M | 7.50% |
| 2019-05-20 | Biotechnology Value Trading Fund OS LP | 390.15K | 1.00% |
| 2019-05-20 | BVF Inc. | 5.51M | 7.50% |
| 2019-05-20 | Mark N. Lampert | 5.51M | 7.50% |
| 2019-05-20 | Biotechnology Value Fund, L.P. | 2.71M | 3.70% |
| 2019-05-20 | BVF Inc. | 5.51M | 7.50% |
| 2019-05-20 | BVF Partners L.P. | 5.51M | 7.50% |
| 2019-05-20 | BVF Partners OS Ltd. | 390.15K | 1.00% |
| 2019-05-20 | Biotechnology Value Fund II, L.P. | 2.19M | 3.00% |
| 2019-05-20 | Biotechnology Value Fund II, L.P. | 2.19M | 3.00% |
| 2019-02-08 | (1) BlackRock, Inc. | 5.62M | 7.60% |
| 2018-12-31 | David E. Shaw | 3.99M | 5.20% |
| 2018-12-31 | 13-3799946 | 3.97M | 5.10% |
| 2018-12-31 | 13-4046559 | 3.93M | 5.10% |
| 2018-12-31 | 13-3695715 | 3.99M | 5.20% |
| 2018-12-31 | 13-4046559 | 3.93M | 5.10% |
| 2018-02-14 | 00-0000000 | - | 0.00% |
| 2018-02-14 | 00-0000000 | - | 0.00% |
| 2018-02-14 | 42-1684320 | - | 0.00% |
| 2018-01-26 | Mark N. Lampert | 2.74M | 5.70% |
| 2018-01-26 | Biotechnology Value Fund, L.P. | 1.29M | 2.70% |
| 2018-01-26 | BVF Partners L.P. | 2.74M | 5.70% |
| 2018-01-26 | BVF Inc. | 2.74M | 5.70% |
| 2018-01-26 | BVF Inc. | 2.74M | 5.70% |
| 2018-01-26 | BVF Partners OS Ltd. | 221.65K | 1.00% |
| 2018-01-26 | BVF Partners OS Ltd. | 221.65K | 1.00% |
| 2018-01-26 | Biotechnology Value Fund, L.P. | 1.29M | 2.70% |
| 2018-01-26 | BVF Partners L.P. | 2.74M | 5.70% |
| 2018-01-26 | Mark N. Lampert | 2.74M | 5.70% |
| 2018-01-26 | Biotechnology Value Fund II, L.P. | 863.52K | 1.80% |
| 2018-01-26 | Biotechnology Value Trading Fund OS LP | 221.65K | 1.00% |
| 2018-01-26 | Biotechnology Value Trading Fund OS LP | 221.65K | 1.00% |
| 2018-01-26 | Biotechnology Value Fund II, L.P. | 863.52K | 1.80% |
| 2017-12-20 | PORTFOLIO SERVICES LTD. | 1.97M | 4.10% |
| 2017-12-20 | KENNETH B. DART | 1.97M | 4.10% |
| 2017-12-20 | EASTERN CAPITAL LIMITED | 1.97M | 4.10% |
| 2017-07-20 | 42-1684320 | 2.86M | 7.70% |
| 2017-07-20 | 00-0000000 | 2.86M | 7.70% |
| 2017-07-20 | 00-0000000 | 2.86M | 7.70% |
| 2017-07-20 | 00-0000000 | 2.86M | 7.70% |
| 2017-07-20 | 00-0000000 | 2.86M | 7.70% |
| 2017-07-20 | 42-1684320 | 2.86M | 7.70% |
| 2017-06-13 | 80-0841812 | 342.35K | 0.93% |
| 2015-02-13 | Select Biotechnology Portfolio | 1.34M | 5.19% |
| 2015-02-13 | FMR LLC | 1.55M | 5.97% |
| 2015-02-13 | Abigail P. Johnson | 1.55M | 5.97% |
| 2015-02-13 | Edward C. Johnson 3d | 1.55M | 5.97% |
| 2015-01-30 | PORTFOLIO SERVICES LTD. | 1.97M | 5.70% |
| 2015-01-30 | PORTFOLIO SERVICES LTD. | 1.97M | 5.70% |
| 2015-01-30 | EASTERN CAPITAL LIMITED | 1.97M | 5.70% |
| 2015-01-30 | KENNETH B. DART | 1.97M | 5.70% |
| 2015-01-30 | EASTERN CAPITAL LIMITED | 1.97M | 5.70% |
| 2015-01-30 | KENNETH B. DART | 1.97M | 5.70% |
| 2014-10-08 | (1) BlackRock, Inc. | 1.14M | 4.40% |
| 2014-01-31 | (1) BlackRock, Inc. | 1.55M | 6.00% |
| 2012-02-03 | KENNETH B. DART | 1.14M | 5.43% |
| 2012-02-03 | KENNETH B. DART | 1.14M | 5.43% |
| 2012-02-03 | EASTERN CAPITAL LIMITED | 1.14M | 5.43% |
| 2012-02-03 | PORTFOLIO SERVICES LTD. | 1.14M | 5.43% |
| 2012-02-03 | PORTFOLIO SERVICES LTD. | 1.14M | 5.43% |
| 2012-02-03 | EASTERN CAPITAL LIMITED | 1.14M | 5.43% |
VSTM Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7.72 | 69.31M | $535.07M | $204.99M | $76.86M | $406.94M |
| 2024-12-31 | $5.17 | 35.71M | $184.64M | $88.82M | $42.25M | $138.07M |
| 2023-12-31 | $8.14 | 22.05M | $179.52M | $77.91M | $41.56M | $143.17M |
| 2022-12-31 | $4.80 | 16.14M | $77.46M | $74.93M | $27.06M | $29.59M |
| 2021-12-31 | $24.60 | 14.53M | $357.53M | $21.25M | $3.18M | $339.46M |
| 2020-12-31 | $25.56 | 12.78M | $326.59M | $67.78M | $22.54M | $281.35M |
| 2019-12-31 | $16.08 | 6.21M | $99.93M | $43.51M | $107.53M | $163.95M |
| 2018-12-31 | $40.32 | 5.78M | $232.92M | $129.87M | $120.45M | $223.5M |
| 2017-12-31 | $36.84 | 3.2M | $117.96M | $82.18M | $14.83M | $50.61M |
| 2016-12-31 | $13.44 | 3.08M | $41.43M | $32.35M | -$ | $9.08M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.82 | 100.12M | $382.44M | $136.35M | $84.33M | $330.42M |
| 2026-03-31 | $5.30 | 98.29M | $520.95M | $165.55M | $85.48M | $440.87M |
| 2025-12-31 | $7.72 | 83.4M | $643.85M | $204.99M | $87.17M | $526.03M |
| 2025-09-30 | $8.83 | 73.16M | $645.98M | $137.71M | $89.48M | $597.75M |
| 2025-06-30 | $4.15 | 66.14M | $274.49M | $164.32M | $84.72M | $194.89M |
| 2025-03-31 | $6.03 | 54.17M | $326.66M | $117.57M | $76.8M | $285.89M |
| 2024-12-31 | $5.17 | 37.99M | $196.39M | $88.82M | $42.25M | $149.82M |
| 2024-09-30 | $2.99 | 40.26M | $120.37M | $113.18M | $41.43M | $48.63M |
| 2024-06-30 | $3.25 | 26.86M | $87.3M | $83.37M | $41.86M | $45.79M |
| 2024-03-31 | $11.73 | 26.83M | $314.74M | $81.32M | $42.28M | $275.71M |
| 2023-12-31 | $8.14 | 26.81M | $218.22M | $77.91M | $41.56M | $181.87M |
| 2023-09-30 | $8.13 | 26.79M | $217.8M | $94.99M | $42.04M | $164.85M |